The Claim
In patients with glycogen storage disease type Ia, conventional therapies that correct hypoglycemia fail to resolve lactic acidosis in all cases, indicating that metabolic decompensation involves mechanisms independent of glucose deficiency.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with glycogen storage disease type Ia, treatments that normalize blood sugar do not always eliminate lactic acidosis, showing that other metabolic factors besides low glucose contribute to this condition.
See the scientific wording
In patients with glycogen storage disease type Ia, conventional therapies that correct hypoglycemia do not reliably resolve lactic acidosis in all cases, indicating that metabolic decompensation may involve mechanisms beyond glucose deficiency.
A genetic defect blocks the body's ability to release glucose from stored sugar, causing sugar intermediates to build up and damage the energy-producing parts of cells. This damage prevents cells from using pyruvate for energy, forcing them to convert pyruvate into lactic acid instead. Over time, the damaged energy factories multiply and fail to clear lactic acid, so even when blood sugar is fixed, lactic acid keeps rising.
What the research says
1 studyEven when doctors gave these patients enough sugar to fix their low blood sugar, their lactic acid levels stayed dangerously high—meaning something else in their bodies, like broken energy factories in cells, was causing the problem.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.